Vraylar 6 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FA4BJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,686
Award facts
- Contract value 100% obligated
- $27,685.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on September 23, 2025, by the Defense Logistics Agency (DLA) for the supply of Vraylar 6 mg capsules (30-count units) under a firm fixed-price contract structure. The award, valued at $27,685.84, represents a single delivery order with an ultimate completion date of September 24, 2025. This non-competitive set-aside award is being performed at the vendor's corporate headquarters location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical procurement needs. Vraylar is a branded antipsychotic medication used in the treatment of psychiatric conditions, reflecting the vendor's ongoing role in supplying neurological and behavioral health medications to the federal healthcare system.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through its established relationship with DLA and its position as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FA4BJ?
SPE2DB25FA4BJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FA4BJ worth?
The government has obligated $27,686 on SPE2DB25FA4BJ.
Is contract SPE2DB25FA4BJ an order under another contract?
Yes. SPE2DB25FA4BJ is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA4BJ competed?
The extent of competition for SPE2DB25FA4BJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award